» Authors » Robin Willixhofer

Robin Willixhofer

Explore the profile of Robin Willixhofer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 8
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Willixhofer R, Ermolaev N, Kronberger C, Eslami M, Vilsmeier J, Rettl R, et al.
Circ Rep . 2025 Feb; 7(2):76-85. PMID: 39931706
Background: This study assessed the prognostic value of submaximal cardiopulmonary exercise testing (CPET) in cardiac amyloidosis and explored CPET as an alternative to the 6-min walk test (6MWT). Methods And...
2.
Kronberger C, Mousavi R, Ermolaev N, Willixhofer R, Rassoulpour N, Kaya M, et al.
Eur J Prev Cardiol . 2025 Jan; PMID: 39862237
Aims: We aimed to establish one-minute sit-to-stand test (1-min STST) cut-off values that align with the guideline-recommended six-minute walk test (6MWT) thresholds (165m and 440m) for one-year mortality risk stratification...
3.
Kronberger C, Mousavi R, Ozturk B, Willixhofer R, Dachs T, Rettl R, et al.
PLoS One . 2025 Jan; 20(1):e0317857. PMID: 39820237
[This corrects the article DOI: 10.1371/journal.pone.0282697.].
4.
Magri D, Ermolaev N, Willixhofer R, Gallo G, Fiori E, Maruotti A, et al.
Heart . 2025 Jan; 111(6):269-277. PMID: 39794925
Background: Little evidence is available about heart rate (HR) response to exercise as well as its relationship with functional capacity in amyloid cardiomyopathy. Then, in a multicentre cohort of patients...
5.
Rettl R, Duca F, Kronberger C, Binder C, Willixhofer R, Ermolaev N, et al.
Eur Heart J Cardiovasc Imaging . 2024 Nov; 26(2):251-260. PMID: 39545930
Aims: Quantification of cardiac [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake enhances diagnostic capabilities and may facilitate prognostic stratification in patients with transthyretin cardiac amyloidosis (ATTR-CA). This study aimed to evaluate the association...
6.
Willixhofer R, Contini M, Emdin M, Magri D, Bonomi A, Salvioni E, et al.
ESC Heart Fail . 2024 Nov; PMID: 39543932
Aims: Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with...
7.
Poledniczek M, Kronberger C, List L, Gregshammer B, Willixhofer R, Ermolaev N, et al.
J Clin Med . 2024 Oct; 13(19). PMID: 39407935
The pathophysiology of heart failure (HF) with preserved ejection fraction (HFpEF) is suggested to be influenced by inflammation. Leukocyte indices, including the neutrophil-lymphocyte ratio (NLR), the monocyte-lymphocyte ratio (MLR), and...
8.
Rettl R, Calabretta R, Duca F, Kronberger C, Binder C, Willixhofer R, et al.
JACC Adv . 2024 Sep; 3(10):101261. PMID: 39309666
Background: The pathophysiological hallmark of wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is the deposition of amyloid within the myocardium. Objectives: This study aimed to investigate associations between quantitative cardiac Tc-3,3-diphosphono-1,2-propanodicarboxylic acid...
9.
Poledniczek M, Kronberger C, Willixhofer R, Ermolaev N, Cherouny B, Dachs T, et al.
Qual Life Res . 2024 Aug; 33(10):2743-2753. PMID: 39105960
Purpose: Transthyretin amyloid cardiomyopathy (ATTR-CM) is associated with severely impaired health-related quality of life (HRQL). HRQL is an independent predictor of outcome in heart failure (HF), but data on patients...
10.
Kronberger C, Mascherbauer K, Willixhofer R, Duca F, Rettl R, Binder-Rodriguez C, et al.
Eur J Intern Med . 2024 Jul; 129:93-99. PMID: 39048334
Background: Heart failure with preserved ejection fraction (HFpEF) is associated with heart failure (HF) hospitalizations and death. Previous studies have shown that altered muscle composition is associated with higher risk...